Grove Biopharma

Grove Biopharma is a preclinical biotechnology startup based in Chicago, operating at the intersection of precision polymers, protein engineering, and medicinal chemistry. The company focuses on therapeutic targeting of protein-protein interactions using its proprietary Precision Linked Proteomimetic chemistry platform. This platform, developed by co-founder Professor Nathan Gianneschi at Northwestern University, enables the creation of customizable, synthetic, protein-scale molecules. Grove Biopharma is a member of the Portal biotech incubator space, which supports its mission to reshape drug discovery. The company serves clients in the pharmaceutical and biotechnology sectors, aiming to advance drug modalities that address complex intracellular interactions. Grove Biopharma generates revenue through partnerships and collaborations with other biotech firms and research institutions. The team includes experts like Brandon Nelson, Ph.D., a Principal Scientist in Chemistry, who brings extensive experience in oncology and small molecule drug discovery from his tenure at AbbVie.

Keywords: biotechnology, drug discovery, proteomimetics, protein interactions, precision polymers, protein engineering, medicinal chemistry, preclinical, Chicago, incubator.